Philip James Wealth Mangement’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Sell
173,727
-10,855
-6% -$1.27M 2.51% 9
2026
Q1
$22.2M Sell
184,582
-395
-0.2% -$45.6K 2.55% 8
2025
Q4
$19.5M Sell
184,977
-6,986
-4% -$656K 2.26% 7
2025
Q3
$16.1M Buy
191,963
+89
+0% +$7.33K 1.88% 7
2025
Q2
$15.2M Buy
191,874
+97,798
+104% +$7.77M 1.94% 8
2025
Q1
$8.44M Buy
94,076
+48,842
+108% +$4.56M 1.03% 18
2024
Q4
$4.5M Sell
45,234
-123
-0.3% -$12.7K 0.58% 43
2024
Q3
$5.15M Buy
+45,357
New +$5.39M 0.63% 38

Other funds holding MRK

Philip James Wealth Mangement's MRK Position: Q2 2026 in Review

Philip James Wealth Mangement reduced its Merck (MRK) stake by 5.9% in Q2 2026, selling an estimated $1.27M and leaving 173,727 shares worth $22.3M. The position accounts for 2.51% of the portfolio, ranked #9.

Philip James Wealth Mangement first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Philip James Wealth Mangement held 173,727 shares of Merck worth $22.3M as of Q2 2026.
  • Philip James Wealth Mangement sold 10,855 Merck shares in Q2 2026, an estimated $1.27M.
  • Merck made up 2.51% of Philip James Wealth Mangement's portfolio in Q2 2026, its #9 holding.
  • Philip James Wealth Mangement first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.